STEPHANIE STROHMEYER: Open Payments
NPI 1447882014 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,500 in 250 payments from 25 companies in 2025. Trend: 2023 $3,259 · 2024 $4,789 · 2025 $4,500
Food & beverage: $4,417Education: $83
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 30 | $545 |
| Incyte Corporation | 19 | $522 |
| ABBVIE INC. | 44 | $481 |
| Janssen Biotech, Inc. | 24 | $475 |
| GENZYME CORPORATION | 17 | $475 |
| UCB, Inc. | 19 | $423 |
| Arcutis Biotherapeutics, Inc. | 23 | $285 |
| LEO Pharma Inc. | 16 | $229 |
| Almirall LLC | 5 | $180 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $126 |
Products named: OPZELURA, TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx, Zoryve, RINVOQ, SKYRIZI.
Industry payments across FL — which companies pay providers there.
